Product Information
AMIODARONE HCL 400 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3876 per EA under NDC 68382029806. Its NADAC has been published 160 times since Jun 7, 2023.
Strength
400 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382029806
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMIODARONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079029On Market Since
2/9/2023
Pharmacological Classes
Price Statistics
The NADAC for AMIODARONE HCL 400 MG TABLET has been published 160 times since Jun 7, 2023, and over the history we have for it it has declined 52.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3876 per EA |
|---|---|
| All-time high | $1.7486 (Mar 13, 2024) |
| All-time low | $0.2214 (Aug 21, 2024) |
| 52-week high | $0.4183 |
| 52-week low | $0.3410 |
| Median price | $0.4160 |
| Average price | $0.6404 |
| Largest weekly change | -74.0% (Mar 20, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the amiodarone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMIODARONE HCL 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 400 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3876 per EA (NDC 68382029806), effective Jun 24, 2026.
How has the price of AMIODARONE HCL 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMIODARONE HCL 400 MG TABLET has declined 52.7%. It has been tracked across 160 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 400 MG TABLET?
Since Jun 7, 2023, the NADAC for AMIODARONE HCL 400 MG TABLET has ranged from a low of $0.2214 (Aug 21, 2024) to a high of $1.7486 (Mar 13, 2024), with a median of $0.4160 per EA.
Are there cheaper alternatives to AMIODARONE HCL 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMIODARONE HCL 400 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures AMIODARONE HCL 400 MG TABLET?
AMIODARONE HCL 400 MG TABLET (NDC 68382029806) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification